In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds

Feng Chen(Wenzhou Medical University), T.S.W Lee(Queen Mary Hospital), Vincent Chi‐Chung Cheng(Queen Mary Hospital), Richard Yi Tsun Kao(University of Hong Kong), Yong Jiang(Hong Kong Baptist University), Haitao Lü, William Tsui(Queen Mary Hospital), Kai-Yang Fan(University of Hong Kong), Kwok Hung Chan(University of Hong Kong), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong)

Journal of Clinical Virology

May 29, 2004

10.1016/j.jcv.2004.03.003

Cited by 541

Related Papers

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

|The Lancet|2020|9.6k

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

|The Lancet Infectious Diseases|2020|3.4k

Consistent Detection of 2019 Novel Coronavirus in Saliva

|Clinical Infectious Diseases|2020|2k

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

|Gastroenterology|2020|1.7k

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

|The Lancet|2020|1.6k